CUE-102
Phase 1Completed 0 watching 0 views this week💤 Quiet
25
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Colorectal Cancer
Conditions
Colorectal Cancer, Gastric Cancer, Pancreatic Cancer, Ovarian Cancer
Trial Timeline
Jun 14, 2022 → Mar 12, 2025
NCT ID
NCT05360680About CUE-102
CUE-102 is a phase 1 stage product being developed by Cue Biopharma for Colorectal Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT05360680. Target conditions include Colorectal Cancer, Gastric Cancer, Pancreatic Cancer.
Hype Score Breakdown
Clinical
10
Activity
5
Company
2
Novelty
3
Community
2
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06917885 | Phase 1 | Recruiting |
| NCT05360680 | Phase 1 | Completed |
Competing Products
20 competing products in Colorectal Cancer